Novartis reported $4.69B in Trade Creditors for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US USD 1.2B 52M
Biogen BIIB:US USD 383.2M 51.6M
Bristol Myers Squibb BMY:US USD 2.6B 287M
Canopy Growth Corp WEED:CN CAD 68.2M 3.56M
Catalent CTLT:US USD 379M 42M
Corcept Therapeutics CORT:US USD 8.18M 68K
Eli Lilly And LLY:US USD 1.68B 23.9M
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Lannett LCI:US USD 24.06M 5.67M
Novartis NOVN:VX USD 4.69B 276M
Pacira Pharmaceuticals PCRX:US USD 12.93M 1.05M
Perrigo Ordinary Shares PRGO:US USD 461.4M 29M
Phibro Animal Health PAHC:US USD 88.38M 7.22M
Prestige Brands PBH:US USD 56.2M 1.91M
Supernus Pharmaceuticals SUPN:US USD 16.02M 19.5M
Teva Pharmaceutical Industries TEVA:US USD 1.64B 266M
Valeant Pharmaceuticals VRX:CN USD 486M 50M
Zoetis ZTS:US USD 373M 57M